Literature DB >> 23458494

Effect of the combinations between pea proteins and soluble fibres on cholesterolaemia and cholesterol metabolism in rats.

Cinzia Parolini1, Stefano Manzini, Marco Busnelli, Elena Rigamonti, Marta Marchesi, Erika Diani, Cesare R Sirtori, Giulia Chiesa.   

Abstract

Many functional foods and dietary supplements have been reported to be beneficial for the management of dyslipidaemia, one of the major risk factors for CVD. Soluble fibres and legume proteins are known to be a safe and practical approach for cholesterol reduction. The present study aimed at investigating the hypocholesterolaemic effect of the combinations of these bioactive vegetable ingredients and their possible effects on the expression of genes regulating cholesterol homeostasis. A total of six groups of twelve rats each were fed, for 28 d, Nath's hypercholesterolaemic diets, differing in protein and fibre sources, being, respectively, casein and cellulose (control), pea proteins and cellulose (pea), casein and oat fibres (oat), casein and apple pectin (pectin), pea proteins and oat fibres (pea+oat) and pea proteins and apple pectin (pea+pectin). Administration of each vegetable-containing diet was associated with lower total cholesterol concentrations compared with the control. The combinations (pea+oat and pea+pectin) were more efficacious than fibres alone in modulating cholesterolaemia ( - 53 and - 54%, respectively, at 28 d; P< 0·005). In rats fed the diets containing oat fibres or apple pectin, alone or in combination with pea proteins, a lower hepatic cholesterol content (P< 0·005) and higher hepatic mRNA concentrations of CYP7A1 and NTCP were found when compared with the control rats (P< 0·05). In summary, the dietary combinations of pea proteins and oat fibres or apple pectin are extremely effective in lowering plasma cholesterol concentrations in rats and affect cellular cholesterol homeostasis by up-regulating genes involved in hepatic cholesterol turnover.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23458494     DOI: 10.1017/S0007114513000639

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  8 in total

1.  Serum lipid profiles, the prevalence of dyslipidemia and the risk factors in two isolated Chinese minorities.

Authors:  Pei-Juan Liao; Rui-Bin Xie; Rui-Xing Yin; Dai-Xun Wei; Jian Huang; Feng Huang; Hui Li; Wei-Xiong Lin; Jin-Zhen Wu; Shang-Ling Pan
Journal:  Int J Clin Exp Med       Date:  2015-10-15

2.  Effects of fibers and gut microbiota on low-grade inflammatory human disease.

Authors:  Cinzia Parolini
Journal:  Hepatobiliary Surg Nutr       Date:  2019-12       Impact factor: 7.293

Review 3.  Lipid Lowering with Soluble Dietary Fiber.

Authors:  Prasanth Surampudi; Byambaa Enkhmaa; Erdembileg Anuurad; Lars Berglund
Journal:  Curr Atheroscler Rep       Date:  2016-12       Impact factor: 5.113

4.  Hypocholesterolaemic effect of rat-administered oral doses of the isolated 7S globulins from cowpeas and adzuki beans.

Authors:  Ederlan S Ferreira; Ana Lucia S Amaral; Aureluce Demonte; Cleslei F Zanelli; Jessica Capraro; Marcello Duranti; Valdir A Neves
Journal:  J Nutr Sci       Date:  2015-02-16

Review 5.  Effects of Vegetables on Cardiovascular Diseases and Related Mechanisms.

Authors:  Guo-Yi Tang; Xiao Meng; Ya Li; Cai-Ning Zhao; Qing Liu; Hua-Bin Li
Journal:  Nutrients       Date:  2017-08-10       Impact factor: 5.717

Review 6.  Effects of Vegetable Proteins on Hypercholesterolemia and Gut Microbiota Modulation.

Authors:  Marco Busnelli; Stefano Manzini; Cesare R Sirtori; Giulia Chiesa; Cinzia Parolini
Journal:  Nutrients       Date:  2018-09-06       Impact factor: 5.717

Review 7.  Mechanisms of Interactions between Bile Acids and Plant Compounds-A Review.

Authors:  Susanne Naumann; Dirk Haller; Peter Eisner; Ute Schweiggert-Weisz
Journal:  Int J Mol Sci       Date:  2020-09-05       Impact factor: 5.923

8.  Biotechnology Approaches for the Treatment of Dyslipidemia.

Authors:  Cinzia Parolini
Journal:  Cardiovasc Drugs Ther       Date:  2021-02       Impact factor: 3.727

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.